COVID-19 Impact on Global Insulin (API & Injection), Market Insights and Forecast to 2026

COVID-19 Impact on Global Insulin (API & Injection), Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Insulin (API & Injection) Product Introduction
1.2 Market Segments
1.3 Key Insulin (API & Injection) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Insulin (API & Injection) Market Size Growth Rate by Type
1.4.2 Animal Insulin
1.4.3 Human Insulin
1.4.4 Insulin Analogue
1.5 Market by Application
1.5.1 Global Insulin (API & Injection) Market Size Growth Rate by Application
1.5.2 Diabetes
1.5.3 Coronary Heart Disease
1.5.4 Perioperation Period
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Insulin (API & Injection) Industry Impact
1.6.1 How the Covid-19 is Affecting the Insulin (API & Injection) Industry
1.6.1.1 Insulin (API & Injection) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Insulin (API & Injection) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Insulin (API & Injection) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Insulin (API & Injection) Market Size Estimates and Forecasts
2.1.1 Global Insulin (API & Injection) Revenue 2015-2026
2.1.2 Global Insulin (API & Injection) Sales 2015-2026
2.2 Insulin (API & Injection) Market Size by Region: 2020 Versus 2026
2.2.1 Global Insulin (API & Injection) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Insulin (API & Injection) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Insulin (API & Injection) Competitor Landscape by Players
3.1 Insulin (API & Injection) Sales by Manufacturers
3.1.1 Insulin (API & Injection) Sales by Manufacturers (2015-2020)
3.1.2 Insulin (API & Injection) Sales Market Share by Manufacturers (2015-2020)
3.2 Insulin (API & Injection) Revenue by Manufacturers
3.2.1 Insulin (API & Injection) Revenue by Manufacturers (2015-2020)
3.2.2 Insulin (API & Injection) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Insulin (API & Injection) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Insulin (API & Injection) Revenue in 2019
3.2.5 Global Insulin (API & Injection) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Insulin (API & Injection) Price by Manufacturers
3.4 Insulin (API & Injection) Manufacturing Base Distribution, Product Types
3.4.1 Insulin (API & Injection) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Insulin (API & Injection) Product Type
3.4.3 Date of International Manufacturers Enter into Insulin (API & Injection) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Insulin (API & Injection) Market Size by Type (2015-2020)
4.1.1 Global Insulin (API & Injection) Sales by Type (2015-2020)
4.1.2 Global Insulin (API & Injection) Revenue by Type (2015-2020)
4.1.3 Insulin (API & Injection) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Insulin (API & Injection) Market Size Forecast by Type (2021-2026)
4.2.1 Global Insulin (API & Injection) Sales Forecast by Type (2021-2026)
4.2.2 Global Insulin (API & Injection) Revenue Forecast by Type (2021-2026)
4.2.3 Insulin (API & Injection) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Insulin (API & Injection) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Insulin (API & Injection) Market Size by Application (2015-2020)
5.1.1 Global Insulin (API & Injection) Sales by Application (2015-2020)
5.1.2 Global Insulin (API & Injection) Revenue by Application (2015-2020)
5.1.3 Insulin (API & Injection) Price by Application (2015-2020)
5.2 Insulin (API & Injection) Market Size Forecast by Application (2021-2026)
5.2.1 Global Insulin (API & Injection) Sales Forecast by Application (2021-2026)
5.2.2 Global Insulin (API & Injection) Revenue Forecast by Application (2021-2026)
5.2.3 Global Insulin (API & Injection) Price Forecast by Application (2021-2026)
6 North America
6.1 North America Insulin (API & Injection) by Country
6.1.1 North America Insulin (API & Injection) Sales by Country
6.1.2 North America Insulin (API & Injection) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Insulin (API & Injection) Market Facts & Figures by Type
6.3 North America Insulin (API & Injection) Market Facts & Figures by Application
7 Europe
7.1 Europe Insulin (API & Injection) by Country
7.1.1 Europe Insulin (API & Injection) Sales by Country
7.1.2 Europe Insulin (API & Injection) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Insulin (API & Injection) Market Facts & Figures by Type
7.3 Europe Insulin (API & Injection) Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Insulin (API & Injection) by Region
8.1.1 Asia Pacific Insulin (API & Injection) Sales by Region
8.1.2 Asia Pacific Insulin (API & Injection) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Insulin (API & Injection) Market Facts & Figures by Type
8.3 Asia Pacific Insulin (API & Injection) Market Facts & Figures by Application
9 Latin America
9.1 Latin America Insulin (API & Injection) by Country
9.1.1 Latin America Insulin (API & Injection) Sales by Country
9.1.2 Latin America Insulin (API & Injection) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Insulin (API & Injection) Market Facts & Figures by Type
9.3 Central & South America Insulin (API & Injection) Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Insulin (API & Injection) by Country
10.1.1 Middle East and Africa Insulin (API & Injection) Sales by Country
10.1.2 Middle East and Africa Insulin (API & Injection) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Insulin (API & Injection) Market Facts & Figures by Type
10.3 Middle East and Africa Insulin (API & Injection) Market Facts & Figures by Application
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Description, Business Overview and Total Revenue
11.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novo Nordisk Insulin (API & Injection) Products Offered
11.1.5 Novo Nordisk Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Corporation Information
11.2.2 Eli Lilly Description, Business Overview and Total Revenue
11.2.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Eli Lilly Insulin (API & Injection) Products Offered
11.2.5 Eli Lilly Recent Development
11.3 Sanofi-Aventis
11.3.1 Sanofi-Aventis Corporation Information
11.3.2 Sanofi-Aventis Description, Business Overview and Total Revenue
11.3.3 Sanofi-Aventis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi-Aventis Insulin (API & Injection) Products Offered
11.3.5 Sanofi-Aventis Recent Development
11.4 Dongbao
11.4.1 Dongbao Corporation Information
11.4.2 Dongbao Description, Business Overview and Total Revenue
11.4.3 Dongbao Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Dongbao Insulin (API & Injection) Products Offered
11.4.5 Dongbao Recent Development
11.5 Bioton
11.5.1 Bioton Corporation Information
11.5.2 Bioton Description, Business Overview and Total Revenue
11.5.3 Bioton Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bioton Insulin (API & Injection) Products Offered
11.5.5 Bioton Recent Development
11.6 United Laboratories
11.6.1 United Laboratories Corporation Information
11.6.2 United Laboratories Description, Business Overview and Total Revenue
11.6.3 United Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.6.4 United Laboratories Insulin (API & Injection) Products Offered
11.6.5 United Laboratories Recent Development
11.7 Merck
11.7.1 Merck Corporation Information
11.7.2 Merck Description, Business Overview and Total Revenue
11.7.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Merck Insulin (API & Injection) Products Offered
11.7.5 Merck Recent Development
11.8 Ganlee
11.8.1 Ganlee Corporation Information
11.8.2 Ganlee Description, Business Overview and Total Revenue
11.8.3 Ganlee Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Ganlee Insulin (API & Injection) Products Offered
11.8.5 Ganlee Recent Development
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Description, Business Overview and Total Revenue
11.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novo Nordisk Insulin (API & Injection) Products Offered
11.1.5 Novo Nordisk Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Insulin (API & Injection) Market Estimates and Projections by Region
12.1.1 Global Insulin (API & Injection) Sales Forecast by Regions 2021-2026
12.1.2 Global Insulin (API & Injection) Revenue Forecast by Regions 2021-2026
12.2 North America Insulin (API & Injection) Market Size Forecast (2021-2026)
12.2.1 North America: Insulin (API & Injection) Sales Forecast (2021-2026)
12.2.2 North America: Insulin (API & Injection) Revenue Forecast (2021-2026)
12.2.3 North America: Insulin (API & Injection) Market Size Forecast by Country (2021-2026)
12.3 Europe Insulin (API & Injection) Market Size Forecast (2021-2026)
12.3.1 Europe: Insulin (API & Injection) Sales Forecast (2021-2026)
12.3.2 Europe: Insulin (API & Injection) Revenue Forecast (2021-2026)
12.3.3 Europe: Insulin (API & Injection) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Insulin (API & Injection) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Insulin (API & Injection) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Insulin (API & Injection) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Insulin (API & Injection) Market Size Forecast by Region (2021-2026)
12.5 Latin America Insulin (API & Injection) Market Size Forecast (2021-2026)
12.5.1 Latin America: Insulin (API & Injection) Sales Forecast (2021-2026)
12.5.2 Latin America: Insulin (API & Injection) Revenue Forecast (2021-2026)
12.5.3 Latin America: Insulin (API & Injection) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Insulin (API & Injection) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Insulin (API & Injection) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Insulin (API & Injection) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Insulin (API & Injection) Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Insulin (API & Injection) Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Insulin (API & Injection) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Insulin (API & Injection) Market Segments
Table 2. Ranking of Global Top Insulin (API & Injection) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Insulin (API & Injection) Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Animal Insulin
Table 5. Major Manufacturers of Human Insulin
Table 6. Major Manufacturers of Insulin Analogue
Table 7. COVID-19 Impact Global Market: (Four Insulin (API & Injection) Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Insulin (API & Injection) Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Insulin (API & Injection) Players to Combat Covid-19 Impact
Table 12. Global Insulin (API & Injection) Market Size Growth Rate by Application 2020-2026 (K MT)
Table 13. Global Insulin (API & Injection) Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 14. Global Insulin (API & Injection) Sales by Regions 2015-2020 (K MT)
Table 15. Global Insulin (API & Injection) Sales Market Share by Regions (2015-2020)
Table 16. Global Insulin (API & Injection) Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Insulin (API & Injection) Sales by Manufacturers (2015-2020) (K MT)
Table 18. Global Insulin (API & Injection) Sales Share by Manufacturers (2015-2020)
Table 19. Global Insulin (API & Injection) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Insulin (API & Injection) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin (API & Injection) as of 2019)
Table 21. Insulin (API & Injection) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Insulin (API & Injection) Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Insulin (API & Injection) Price (2015-2020) (USD/MT)
Table 24. Insulin (API & Injection) Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Insulin (API & Injection) Product Type
Table 26. Date of International Manufacturers Enter into Insulin (API & Injection) Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Insulin (API & Injection) Sales by Type (2015-2020) (K MT)
Table 29. Global Insulin (API & Injection) Sales Share by Type (2015-2020)
Table 30. Global Insulin (API & Injection) Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Insulin (API & Injection) Revenue Share by Type (2015-2020)
Table 32. Insulin (API & Injection) Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 33. Global Insulin (API & Injection) Sales by Application (2015-2020) (K MT)
Table 34. Global Insulin (API & Injection) Sales Share by Application (2015-2020)
Table 35. North America Insulin (API & Injection) Sales by Country (2015-2020) (K MT)
Table 36. North America Insulin (API & Injection) Sales Market Share by Country (2015-2020)
Table 37. North America Insulin (API & Injection) Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Insulin (API & Injection) Revenue Market Share by Country (2015-2020)
Table 39. North America Insulin (API & Injection) Sales by Type (2015-2020) (K MT)
Table 40. North America Insulin (API & Injection) Sales Market Share by Type (2015-2020)
Table 41. North America Insulin (API & Injection) Sales by Application (2015-2020) (K MT)
Table 42. North America Insulin (API & Injection) Sales Market Share by Application (2015-2020)
Table 43. Europe Insulin (API & Injection) Sales by Country (2015-2020) (K MT)
Table 44. Europe Insulin (API & Injection) Sales Market Share by Country (2015-2020)
Table 45. Europe Insulin (API & Injection) Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Insulin (API & Injection) Revenue Market Share by Country (2015-2020)
Table 47. Europe Insulin (API & Injection) Sales by Type (2015-2020) (K MT)
Table 48. Europe Insulin (API & Injection) Sales Market Share by Type (2015-2020)
Table 49. Europe Insulin (API & Injection) Sales by Application (2015-2020) (K MT)
Table 50. Europe Insulin (API & Injection) Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Insulin (API & Injection) Sales by Region (2015-2020) (K MT)
Table 52. Asia Pacific Insulin (API & Injection) Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Insulin (API & Injection) Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Insulin (API & Injection) Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Insulin (API & Injection) Sales by Type (2015-2020) (K MT)
Table 56. Asia Pacific Insulin (API & Injection) Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Insulin (API & Injection) Sales by Application (2015-2020) (K MT)
Table 58. Asia Pacific Insulin (API & Injection) Sales Market Share by Application (2015-2020)
Table 59. Latin America Insulin (API & Injection) Sales by Country (2015-2020) (K MT)
Table 60. Latin America Insulin (API & Injection) Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Insulin (API & Injection) Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Insulin (API & Injection) Revenue Market Share by Country (2015-2020)
Table 63. Latin America Insulin (API & Injection) Sales by Type (2015-2020) (K MT)
Table 64. Latin America Insulin (API & Injection) Sales Market Share by Type (2015-2020)
Table 65. Latin America Insulin (API & Injection) Sales by Application (2015-2020) (K MT)
Table 66. Latin America Insulin (API & Injection) Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Insulin (API & Injection) Sales by Country (2015-2020) (K MT)
Table 68. Middle East and Africa Insulin (API & Injection) Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Insulin (API & Injection) Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Insulin (API & Injection) Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Insulin (API & Injection) Sales by Type (2015-2020) (K MT)
Table 72. Middle East and Africa Insulin (API & Injection) Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Insulin (API & Injection) Sales by Application (2015-2020) (K MT)
Table 74. Middle East and Africa Insulin (API & Injection) Sales Market Share by Application (2015-2020)
Table 75. Novo Nordisk Corporation Information
Table 76. Novo Nordisk Description and Major Businesses
Table 77. Novo Nordisk Insulin (API & Injection) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Novo Nordisk Product
Table 79. Novo Nordisk Recent Development
Table 80. Eli Lilly Corporation Information
Table 81. Eli Lilly Description and Major Businesses
Table 82. Eli Lilly Insulin (API & Injection) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Eli Lilly Product
Table 84. Eli Lilly Recent Development
Table 85. Sanofi-Aventis Corporation Information
Table 86. Sanofi-Aventis Description and Major Businesses
Table 87. Sanofi-Aventis Insulin (API & Injection) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Sanofi-Aventis Product
Table 89. Sanofi-Aventis Recent Development
Table 90. Dongbao Corporation Information
Table 91. Dongbao Description and Major Businesses
Table 92. Dongbao Insulin (API & Injection) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Dongbao Product
Table 94. Dongbao Recent Development
Table 95. Bioton Corporation Information
Table 96. Bioton Description and Major Businesses
Table 97. Bioton Insulin (API & Injection) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Bioton Product
Table 99. Bioton Recent Development
Table 100. United Laboratories Corporation Information
Table 101. United Laboratories Description and Major Businesses
Table 102. United Laboratories Insulin (API & Injection) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. United Laboratories Product
Table 104. United Laboratories Recent Development
Table 105. Merck Corporation Information
Table 106. Merck Description and Major Businesses
Table 107. Merck Insulin (API & Injection) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Merck Product
Table 109. Merck Recent Development
Table 110. Ganlee Corporation Information
Table 111. Ganlee Description and Major Businesses
Table 112. Ganlee Insulin (API & Injection) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Ganlee Product
Table 114. Ganlee Recent Development
Table 115. Global Insulin (API & Injection) Sales Forecast by Regions (2021-2026) (K MT)
Table 116. Global Insulin (API & Injection) Sales Market Share Forecast by Regions (2021-2026)
Table 117. Global Insulin (API & Injection) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 118. Global Insulin (API & Injection) Revenue Market Share Forecast by Regions (2021-2026)
Table 119. North America: Insulin (API & Injection) Sales Forecast by Country (2021-2026) (K MT)
Table 120. North America: Insulin (API & Injection) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Europe: Insulin (API & Injection) Sales Forecast by Country (2021-2026) (K MT)
Table 122. Europe: Insulin (API & Injection) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Asia Pacific: Insulin (API & Injection) Sales Forecast by Region (2021-2026) (K MT)
Table 124. Asia Pacific: Insulin (API & Injection) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 125. Latin America: Insulin (API & Injection) Sales Forecast by Country (2021-2026) (K MT)
Table 126. Latin America: Insulin (API & Injection) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Middle East and Africa: Insulin (API & Injection) Sales Forecast by Country (2021-2026) (K MT)
Table 128. Middle East and Africa: Insulin (API & Injection) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 130. Key Challenges
Table 131. Market Risks
Table 132. Main Points Interviewed from Key Insulin (API & Injection) Players
Table 133. Insulin (API & Injection) Customers List
Table 134. Insulin (API & Injection) Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin (API & Injection) Product Picture
Figure 2. Global Insulin (API & Injection) Sales Market Share by Type in 2020 & 2026
Figure 3. Animal Insulin Product Picture
Figure 4. Human Insulin Product Picture
Figure 5. Insulin Analogue Product Picture
Figure 6. Global Insulin (API & Injection) Sales Market Share by Application in 2020 & 2026
Figure 7. Diabetes
Figure 8. Coronary Heart Disease
Figure 9. Perioperation Period
Figure 10. Others
Figure 11. Insulin (API & Injection) Report Years Considered
Figure 12. Global Insulin (API & Injection) Market Size 2015-2026 (US$ Million)
Figure 13. Global Insulin (API & Injection) Sales 2015-2026 (K MT)
Figure 14. Global Insulin (API & Injection) Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Insulin (API & Injection) Sales Market Share by Region (2015-2020)
Figure 16. Global Insulin (API & Injection) Sales Market Share by Region in 2019
Figure 17. Global Insulin (API & Injection) Revenue Market Share by Region (2015-2020)
Figure 18. Global Insulin (API & Injection) Revenue Market Share by Region in 2019
Figure 19. Global Insulin (API & Injection) Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Insulin (API & Injection) Revenue in 2019
Figure 21. Insulin (API & Injection) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Insulin (API & Injection) Sales Market Share by Type (2015-2020)
Figure 23. Global Insulin (API & Injection) Sales Market Share by Type in 2019
Figure 24. Global Insulin (API & Injection) Revenue Market Share by Type (2015-2020)
Figure 25. Global Insulin (API & Injection) Revenue Market Share by Type in 2019
Figure 26. Global Insulin (API & Injection) Market Share by Price Range (2015-2020)
Figure 27. Global Insulin (API & Injection) Sales Market Share by Application (2015-2020)
Figure 28. Global Insulin (API & Injection) Sales Market Share by Application in 2019
Figure 29. Global Insulin (API & Injection) Revenue Market Share by Application (2015-2020)
Figure 30. Global Insulin (API & Injection) Revenue Market Share by Application in 2019
Figure 31. North America Insulin (API & Injection) Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Insulin (API & Injection) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Insulin (API & Injection) Sales Market Share by Country in 2019
Figure 34. North America Insulin (API & Injection) Revenue Market Share by Country in 2019
Figure 35. U.S. Insulin (API & Injection) Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Insulin (API & Injection) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Insulin (API & Injection) Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Insulin (API & Injection) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Insulin (API & Injection) Market Share by Type in 2019
Figure 40. North America Insulin (API & Injection) Market Share by Application in 2019
Figure 41. Europe Insulin (API & Injection) Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Insulin (API & Injection) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Insulin (API & Injection) Sales Market Share by Country in 2019
Figure 44. Europe Insulin (API & Injection) Revenue Market Share by Country in 2019
Figure 45. Germany Insulin (API & Injection) Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Insulin (API & Injection) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Insulin (API & Injection) Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Insulin (API & Injection) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Insulin (API & Injection) Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Insulin (API & Injection) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Insulin (API & Injection) Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Insulin (API & Injection) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Insulin (API & Injection) Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Insulin (API & Injection) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Insulin (API & Injection) Market Share by Type in 2019
Figure 56. Europe Insulin (API & Injection) Market Share by Application in 2019
Figure 57. Asia Pacific Insulin (API & Injection) Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Insulin (API & Injection) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Insulin (API & Injection) Sales Market Share by Region in 2019
Figure 60. Asia Pacific Insulin (API & Injection) Revenue Market Share by Region in 2019
Figure 61. China Insulin (API & Injection) Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Insulin (API & Injection) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Insulin (API & Injection) Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Insulin (API & Injection) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Insulin (API & Injection) Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Insulin (API & Injection) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Insulin (API & Injection) Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Insulin (API & Injection) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Insulin (API & Injection) Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Insulin (API & Injection) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Insulin (API & Injection) Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Insulin (API & Injection) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Insulin (API & Injection) Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Insulin (API & Injection) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Insulin (API & Injection) Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Insulin (API & Injection) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Insulin (API & Injection) Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Insulin (API & Injection) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Insulin (API & Injection) Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Insulin (API & Injection) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Insulin (API & Injection) Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Insulin (API & Injection) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Insulin (API & Injection) Market Share by Type in 2019
Figure 84. Asia Pacific Insulin (API & Injection) Market Share by Application in 2019
Figure 85. Latin America Insulin (API & Injection) Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Insulin (API & Injection) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Insulin (API & Injection) Sales Market Share by Country in 2019
Figure 88. Latin America Insulin (API & Injection) Revenue Market Share by Country in 2019
Figure 89. Mexico Insulin (API & Injection) Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Insulin (API & Injection) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Insulin (API & Injection) Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Insulin (API & Injection) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Insulin (API & Injection) Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Insulin (API & Injection) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Insulin (API & Injection) Market Share by Type in 2019
Figure 96. Latin America Insulin (API & Injection) Market Share by Application in 2019
Figure 97. Middle East and Africa Insulin (API & Injection) Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Insulin (API & Injection) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Insulin (API & Injection) Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Insulin (API & Injection) Revenue Market Share by Country in 2019
Figure 101. Turkey Insulin (API & Injection) Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Insulin (API & Injection) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Insulin (API & Injection) Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Insulin (API & Injection) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Insulin (API & Injection) Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Insulin (API & Injection) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Insulin (API & Injection) Market Share by Type in 2019
Figure 108. Middle East and Africa Insulin (API & Injection) Market Share by Application in 2019
Figure 109. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Sanofi-Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Dongbao Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Bioton Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. United Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Ganlee Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. North America Insulin (API & Injection) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. North America Insulin (API & Injection) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Europe Insulin (API & Injection) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Europe Insulin (API & Injection) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Asia Pacific Insulin (API & Injection) Sales Growth Rate Forecast (20

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Metformin Hydrochloride Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......

Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......

Global Insulin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101

According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......

Global Insulin API Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......

Global Glucagon Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101

According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global Acarbose Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global Insulin Glargine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77

According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......

Global Liraglutide Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103

According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs